Risk factors for tissue expander infection in scar reconstruction: a retrospective cohort study of 2374 consecutive cases
Chen Dong , Minhui Zhu , Luguang Huang , Wei Liu , Hengxin Liu , Kun Jiang , Zhou Yu , Xianjie Ma
Burns & Trauma ›› 2021, Vol. 9 ›› Issue (1) : tkaa037
Background: Tissue expansion is used for scar reconstruction owing to its excellent clinical outcomes; however, the complications that emerge from tissue expansion hinder repair. Infection is considered a major complication of tissue expansion. This study aimed to analyze the perioperative risk factors for expander infection. Methods: A large, retrospective, single-institution observational study was carried out over a 10-year period. The study enrolled consecutive patients who had undergone tissue expansion for scar reconstruction. Demographics, etiological data, expander-related characteristics and post-operative infection were assessed. Univariate and multivariate logistic regression analysis were performed to identify risk factors for expander infection. In addition, we conducted a sensitivity analysis for treatment failure caused by infection as an outcome. Results: A total of 2374 expanders and 148 cases of expander infection were assessed. Treatment failure caused by infection occurred in 14 expanders. Multivariate logistic regression analysis identified that disease duration of ≤1 year (odds ratio (OR), 2.07; p <0.001), larger volume of expander (200–400 ml vs <200 ml; OR, 1.74; p=0.032; >400 ml vs <200 ml; OR, 1.76; p=0.049), limb location (OR, 2.22; p=0.023) and hematoma evacuation (OR, 2.17; p=0.049) were associated with a high likelihood of expander infection. Disease duration of ≤1 year (OR, 3.88; p=0.015) and hematoma evacuation (OR, 10.35; p=0.001) were so related to high risk of treatment failure. Conclusions: The rate of expander infection in patients undergoing scar reconstruction was 6.2%. Disease duration of <1 year, expander volume of >200 ml, limb location and postoperative hematoma evacuation were independent risk factors for expander infection.
Tissue expansion / Tissue expander / Scar reconstruction / Risk factors / Infection
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
/
| 〈 |
|
〉 |